TABLE 1.
Study Characteristicsa
| Study: Design | Patients, n | Mean Age, y | Male:Female, n | Follow-up, mo | Jadad or NOS Score |
|---|---|---|---|---|---|
| Barrett et al (2002)2: CS | 7 | ||||
| BPB | 37 | 25.2 | 0:37 | 52 | |
| HT | 39 | 23.2 | 0:39 | 40.9 | |
| Ibrahim et al (2005)18: PCS | 22.3 | 81 | 9 | ||
| BPB | 40 | 40:0 | |||
| HT | 45 | 45:0 | |||
| Taylor et al (2009)40: RCT | 36 | 3 | |||
| BPB | 32 | 21.7 | 25:7 | ||
| HT | 32b | 22.1 | 28:4 | ||
| Mohtadi et al (2016)25: RCT | 5 | ||||
| BPB | 110 | 28.7 | 63:47 | 24 | |
| HT | 110 | 28.5 | 59:51 | 24 | |
| Webster et al (2016)43,c: RCT | 5 | ||||
| BPB | 22 | 26.6 | 16:6 | 184 | |
| HT | 25 | 26.1 | 20:5 | 182 | |
| Feller and Webster (2003)13,c: RCT | 5 | ||||
| BPB | 31 | 25.8 | 23:8 | 36 | |
| HT | 34 | 26.3 | 24:10 | 36 |
aBPB, bone–patellar tendon–bone; CS, case series; HT, hamstring tendon; NOS, Newcastle-Ottawa Scale; PCS, prospective cohort study; RCT, randomized controlled trial.
bThere were 8 patients in the BPB group and 3 in the HT group lost to follow-up.
cThese studies reported on the same cohort and were considered 1 study.